Eli Lilly and Company

Rhea Sirkar

Lampros Kourtis

Jeffrey L Ellis

Anthony David Duong

Christopher Kovalchick

Corrie Bennison

Christopher John Demaria

Daniel Morris Hartmann

Sean Matthew Pszenny

John Paul Tallarico

Monica Rixman Swinney

Michael W Harrison

Graham Barry Jones

Jeffrey Leclair Ellis

Lampros C Kourtis

Corrie Jo Bennison

A chemical reaction system is disclosed for use in a device for delivering a therapeutic fluid comprising a liquid base and a polymeric acid. A reaction rate of the chemical reaction system is capable of being adjusted by adjusting at least one of surface area-to-volume ratio, acid concentration, and cross-linking of the polymeric acid.

System for controlling gas generation within a drug delivery device

An insulin infusion set (IIS) device with one or more features designed to achieve longevity in a patients continuous subcutaneous insulin infusion (CSII) site viability. One exemplary feature is an adsorbent material configured to adsorb phenolic excipients (e.g., m-cresol or other preservatives) from the insulin formulation. The adsorbent material may be positioned along a fluid pathway specifically designed to increase and/or extend exposure between the insulin formulation and the adsorbent material. Another exemplary feature is a medicament configured to reduce the patients inflammation or slow the progression of the patients inflammatory response. Yet another exemplary feature is a diffusive catheter configured to deliver the insulin formulation in a diffuse manner.

Infusion set with components comprising a polymeric sorbent to reduce the concentration of m-cresol in insulin

Growing community of inventors

Brighton, MA, United States of America

Rhea Sirkar